Healio

FDA clears investigational new drug application for Fragile X treatment

Please provide your email address to receive an email when new articles are posted on . The FDA has cleared an investigational new drug application for a small molecule therapeutic to treat those with ...
Healio

FDA clears investigational new drug application for ICP-332

Please provide your email address to receive an email when new articles are posted on . ICP-332’s investigational new drug application was accepted by the FDA. ICP-332 is a TYK2 inhibitor that has ...
Lupus Foundation of America

Investigational New Drug Application for ATA3219 Submitted to the FDA for Lupus Nephritis Treatment

A new drug application for the investigational therapy, ATA3219, for treatment of systemic lupus erythematosus (SLE) with kidney involvement (lupus nephritis) has been submitted to the U.S. Food and ...
Business Wire

Arcturus Therapeutics Receives Clearance of an Investigational New Drug Application to U.S. Food and Drug Administration for ARCT-032, an Investigational Inhaled mRNA ...

SAN DIEGO--(BUSINESS WIRE)--Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a global messenger RNA medicines company focused on the development of infectious disease ...
Cure Today

New Cancer Vaccine, EVM14, Cleared for Investigational Drug Application

EVM14, an mRNA cancer vaccine, received FDA clearance for investigational new drug application, advancing Everest's mRNA technology to global clinical trials. Preclinical studies showed EVM14 induces ...
Morningstar

Avenzo Therapeutics Announces FDA Clearance of Investigational New Drug Application for AVZO-103, a Potential Best-in-Class Nectin4/TROP2 Bispecific Antibody-Drug Conjugate

Avenzo Therapeutics, Inc. (“Avenzo”), a clinical-stage biotechnology company developing next-generation oncology therapies, today announced clearance by the U.S. Food and Drug Administration (FDA) of ...